Pharmacodynamic observations on metronidazole therapy. Side effects in endocrine, metabolic and auto-immune disorders. 3. Anti-ischemic and anti-inflammatory action in peripheral vascular disorders.
D001775:Blood Circulation / Q000187:drug effects; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D048909:Diabetes Complications; D004692:Endarteritis / Q000188:drug therapy*; D004893:Erythema Nodosum / Q000150:complications; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008795:Metronidazole / Q000627:therapeutic use*; D010201:Panniculitis, Nodular Nonsuppurative / Q000150:complications; D010488:Polyarteritis Nodosa / Q000188:drug therapy*; D011832:Radiation Injuries / Q000188:drug therapy*; D011928:Raynaud Disease / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D012909:Snake Bites / Q000188:drug therapy*; D013927:Thrombosis / Q000188:drug therapy*; D014647:Varicose Ulcer / Q000188:drug therapy*; D014652:Vascular Diseases / Q000188:drug therapy*
D008795:Metronidazole